Is a complete NXTC research report available?

No complete published report is available for NextCure, Inc. (NXTC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NextCure, Inc. (NXTC)

NASDAQ: NXTC · USD

$5.94

+0.23 (+3.9%)· Recorded snapshot

Market cap	27.2M
Net income (ttm)	-42.7M
EPS (ttm)	-$9.94
Shares out	4.6M
Volume	62,777
Beta	1.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -42.7M
EPS (ttm): -$9.94
Market cap: 27.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001661059
Company name	NextCure, Inc.
Country	United States
Country code	US
CUSIP number	65343E207
Earnings date	2026-11-09
Earnings time	amc
Employees	40
Employees change	-3
Employees growth	-6.98%
Enterprise value	$11.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Biotechnology
IPO date	2019-05-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US65343E2072
Last 10-K release date	2026-03-05
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2025-07-14
Last stock split type	Reverse
Market cap	$27.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	No
Price	$5.94
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	NXTC
U.S. state	Maryland
Website	https://www.nextcure.com

Metric

Value

Amount currency

USD

CIK code

0001661059

Company name

NextCure, Inc.

Country

United States

Country code

CUSIP number

65343E207

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

-3

Employees growth

-6.98%

Enterprise value

$11.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

Industry

Biotechnology

IPO date

2019-05-09

Is primary listing

Yes

Is SPAC

ISIN number

US65343E2072

Last 10-K release date

2026-03-05

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2025-07-14

Last stock split type

Reverse

Market cap

$27.2M

Market cap category

Nano-Cap

Next earnings date

2026-11-09

Options

Price

$5.94

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

NXTC

U.S. state

Maryland

Website

https://www.nextcure.com

Metric	Value
Earnings yield	-167.26%
FCF / EV yield	-344.43%
FCF yield	-141.38%
P/B ratio	1.91x
Price / tangible book value	2.15x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-167.26%

FCF / EV yield

-344.43%

FCF yield

-141.38%

P/B ratio

1.91x

Price / tangible book value

2.15x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Profit per employee	$-1.1M
ROA	-69.02%
ROA (5Y)	-30.93%
ROCE	-239.55%
ROE	-204.56%
ROE (5Y)	-56.24%
ROIC	-93.24%

Metric

Value

Profit per employee

$-1.1M

ROA

-69.02%

ROA (5Y)

-30.93%

ROCE

-239.55%

ROE

-204.56%

ROE (5Y)

-56.24%

ROIC

-93.24%

Metric	Value
EPS growth quarters	4
EPS growth years	3
Net income growth quarters	4
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$1.5M
EBIT	$-38.8M
EBITDA	$-37.4M
EPS	$-9.94
FCF per share	$-8.08
Financing cash flow	$21.6M
Free cash flow	$-37M
Free cash flow minus SBC	$-38.7M
Investing cash flow	$25.8M
Net cash flow	$10.4M
Net income	$-42.7M
Operating cash flow minus SBC	$-38.7M
Operating income	$-38.8M
Stock-based compensation	$1.7M

Metric

Value

Depreciation and amortization

$1.5M

EBIT

$-38.8M

EBITDA

$-37.4M

EPS

$-9.94

FCF per share

$-8.08

Financing cash flow

$21.6M

Free cash flow

$-37M

Free cash flow minus SBC

$-38.7M

Investing cash flow

$25.8M

Net cash flow

$10.4M

Net income

$-42.7M

Operating cash flow minus SBC

$-38.7M

Operating income

$-38.8M

Stock-based compensation

$1.7M

Metric	Value
Book value per share	$2.99
Debt / equity	0.38
Long-term assets	$365,000
Long-term liabilities	$4.1M
Net cash (debt)	$15.4M
Net cash / market cap	58.95%
Net cash growth	-48.11%
Net debt / equity	-1.27
Piotroski F-Score	1
Property, plant and equipment	$283,000
Shareholders' equity	$12.1M
Tangible book value	$12.1M
Tangible book value per share	$2.99
Total assets	$22.6M
Total cash	$20.1M
Total debt	$4.7M
Total liabilities	$10.5M
WACC	9.89%

Metric

Value

Book value per share

$2.99

Debt / equity

0.38

Long-term assets

$365,000

Long-term liabilities

$4.1M

Net cash (debt)

$15.4M

Net cash / market cap

58.95%

Net cash growth

-48.11%

Net debt / equity

-1.27

Piotroski F-Score

Property, plant and equipment

$283,000

Shareholders' equity

$12.1M

Tangible book value

$12.1M

Tangible book value per share

$2.99

Total assets

$22.6M

Total cash

$20.1M

Total debt

$4.7M

Total liabilities

$10.5M

WACC

9.89%

Metric	Value
Current assets	$22.3M
Current liabilities	$6.4M
Current ratio	3.47
Net working capital	$-3.2M
Quick ratio	3.15
Working capital	$15.8M

Metric

Value

Current assets

$22.3M

Current liabilities

$6.4M

Current ratio

3.47

Net working capital

$-3.2M

Quick ratio

3.15

Working capital

$15.8M

Metric	Value
Buyback yield / dilution	-83.59%
Dividend yield	0%
Shareholder yield	-83.59%

Metric

Value

Buyback yield / dilution

-83.59%

Dividend yield

Shareholder yield

-83.59%

Metric	Value
150-day SMA	$6.48
1D price change	3.94%
1M price change	23.23%
1M total return	23.23%
1W price change	15.07%
1W total return	15.07%
1Y price change	-32.47%
1Y return CAGR	-32.49%
1Y total return	-32.47%
20-day SMA	$5.87
200-day SMA	$7.91
3M price change	22.27%
3M total return	22.27%
3Y price change	-51.02%
3Y return CAGR	-21.17%
3Y total return	-51.02%
50-day SMA	$6.10
50-day SMA vs 200-day SMA	50under200
52-week high	$15.74
52-week high date	2025-11-24
52-week low	$1.55
52-week low date	2026-06-26
5Y price change	-93.37%
5Y return CAGR	-41.89%
5Y total return	-93.37%
6M price change	-34.93%
6M total return	-34.93%
All-time high	$1,308.00
All-time high date	2019-11-05
All-time low	$1.55
All-time low date	2026-06-26
Average true range (ATR)	$0.82
Average volume	71.8K
Beta (1Y)	2.18
Beta (2Y)	1.24
Beta (5Y)	1.35
Change from 52-week high	-62.26%
Change from 52-week low	283.23%
Change from all-time high	-99.52%
Change from all-time low	303.87%
Change from open	5.32%
Day's gap	-1.4%
Dollar volume	$372,895
High price	$6.00
Low price	$5.60
Monthly RSI	41.85
Open price	$5.64
Position in 52-week range	85%
Premarket change	1.61%
Premarket close	$5.72
Premarket price	$5.81
Previous close	$5.72
Price vs 150-day SMA	-3.44%
Price vs 20-day SMA	6.68%
Price vs 200-day SMA	-20.9%
Price vs 50-day SMA	2.62%
Relative volume	0.87
Return from IPO open	-96.94%
Return from IPO price	-61.9%
RSI	54.45
Sharpe ratio	0.55
Sharpe ratio (3Y)	0.33
Sharpe ratio (5Y)	-0.03
Sortino ratio	1.5
Sortino ratio (3Y)	0.77
Sortino ratio (5Y)	0.01
Volume	62.8K
Weekly RSI	48.67
YTD price change	-55.88%
YTD total return	-55.88%

Metric

Value

150-day SMA

$6.48

1D price change

3.94%

1M price change

23.23%

1M total return

23.23%

1W price change

15.07%

1W total return

15.07%

1Y price change

-32.47%

1Y return CAGR

-32.49%

1Y total return

-32.47%

20-day SMA

$5.87

200-day SMA

$7.91

3M price change

22.27%

3M total return

22.27%

3Y price change

-51.02%

3Y return CAGR

-21.17%

3Y total return

-51.02%

50-day SMA

$6.10

50-day SMA vs 200-day SMA

50under200

52-week high

$15.74

52-week high date

2025-11-24

52-week low

$1.55

52-week low date

2026-06-26

5Y price change

-93.37%

5Y return CAGR

-41.89%

5Y total return

-93.37%

6M price change

-34.93%

6M total return

-34.93%

All-time high

$1,308.00

All-time high date

2019-11-05

All-time low

$1.55

All-time low date

2026-06-26

Average true range (ATR)

$0.82

Average volume

71.8K

Beta (1Y)

2.18

Beta (2Y)

1.24

Beta (5Y)

1.35

Change from 52-week high

-62.26%

Change from 52-week low

283.23%

Change from all-time high

-99.52%

Change from all-time low

303.87%

Change from open

5.32%

Day's gap

-1.4%

Dollar volume

$372,895

High price

$6.00

Low price

$5.60

Monthly RSI

41.85

Open price

$5.64

Position in 52-week range

85%

Premarket change

1.61%

Premarket close

$5.72

Premarket price

$5.81

Previous close

$5.72

Price vs 150-day SMA

-3.44%

Price vs 20-day SMA

6.68%

Price vs 200-day SMA

-20.9%

Price vs 50-day SMA

2.62%

Relative volume

0.87

Return from IPO open

-96.94%

Return from IPO price

-61.9%

RSI

54.45

Sharpe ratio

0.55

Sharpe ratio (3Y)

0.33

Sharpe ratio (5Y)

-0.03

Sortino ratio

1.5

Sortino ratio (3Y)

0.77

Sortino ratio (5Y)

0.01

Volume

62.8K

Weekly RSI

48.67

YTD price change

-55.88%

YTD total return

-55.88%

Metric	Value
Float	2.9M
Float percentage	64.1%
Shares change (QoQ)	1.35%
Shares change (YoY)	83.59%
Shares held by insiders	1.02%
Shares held by institutions	35.79%
Shares outstanding	4.6M
Short % of float	7.27%
Short % of shares	4.66%
Short ratio	2 days

Metric

Value

Float

2.9M

Float percentage

64.1%

Shares change (QoQ)

1.35%

Shares change (YoY)

83.59%

Shares held by insiders

1.02%

Shares held by institutions

35.79%

Shares outstanding

4.6M

Short % of float

7.27%

Short % of shares

4.66%

Short ratio

2 days

NextCure, Inc. (NXTC)

Price

Financial snapshot

Fair-value bridge

Latest news · NXTC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NXTC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NXTC

Frequently asked questions